New research on the ties between bacteria and inflammatory disease.
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
New Diagnostic Criteria for Axial Spondylarthritis
New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.
Reactive Arthritis
Back to the Future
Reactive Arthritis
Reactive arthritis is highlighted this month in our ongoing series on patient education materials.